Skip to content

RPO NucleoGenesis: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

RPO NucleoGenesis

BE 0782.980.238
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
Print or PDF Dossier
Only one financial year

Comparing needs two financial years with figures read; this company has one.

We would like to set cookies. That happens only with your consent. What we measure